Sign In
Buy TAK
$15.03
-0.150 (-0.99%)
At Close: Jun 03, 2026
Moderna partners with Takeda, Japanese government on additional 50 million COVID-19 vaccine doses
06:51am, Tuesday, 20'th Jul 2021
Shares of Moderna Inc. rose 1.4% in premarket trading Tuesday, after the biotechnology company said it has partnered with Takeda Pharmaceutical Co. Ltd. and the Ministry of Health, Labour and Welfare
OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced results from two final analyses from the Phase 3 HELP (Hereditary Angioedema Lon
ZURICH & BRUSSELS--(BUSINESS WIRE)--The European Federation of Crohn's and Ulcerative Colitis Associations (“EFCCA”) in collaboration with Takeda Pharmaceutical Company Limited (“Takeda”) toda
Catabasis Pharmaceuticals: Transformation Through Quellis Biosciences Acquisition
02:24am, Wednesday, 30'th Jun 2021
Catabasis Pharmaceuticals: Transformation Through Quellis Biosciences Acquisition
Takeda introduces the In Their Shoes experience to the Middle East in support of the IBD patient community
12:21pm, Wednesday, 09'th Jun 2021
DUBAI, UAE, June 9, 2021 /PRNewswire/ -- Takeda (TSE: 4502) (NYSE: TAK) has introduced the "In Their Shoes" platform, an award-winning, immersive simulation program to promote greater awareness an
Losers Outnumber Gainers in Biotech IPOs This Year
05:51pm, Tuesday, 01'st Jun 2021
Is investor enthusiasm for new biotechnology companies waning? Based on the performance of the 35 biotechs that went public in the first quarter, that may be the case.
Takeda's Dengue Vaccine Effective In Reducing Hospitalization Regardless Of Prior Infection
08:05am, Monday, 24'th May 2021
Takeda Pharmaceutical Co Ltd (NYSE: TAK) unveiled long-term data for its dengue vaccine candidate (TAK-003), showing the shot's efficacy waned over time but that it was still “robust” in preven
Potential Impact of Takeda's Dengue Vaccine Candidate Reinforced by Long-Term Safety and Efficacy Results
11:15am, Saturday, 22'nd May 2021
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that its dengue vaccine candidate (TAK-003) demonstrated cont
Takeda's Maribavir US Application For Post-Transplant CMV Infection Under Review
08:16am, Friday, 21'st May 2021
The FDA has accepted for review Takeda Pharmaceutical Co Ltd's (NYSE TAK) marketing application for maribavir for cytomegalovirus (CMV) Infection. The application under priority review is seeking m
OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the U.S. Food & Drug Administration (
Takeda Announces Approval of Moderna's COVID-19 Vaccine in Japan
12:53am, Friday, 21'st May 2021
OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the Ministry of Health, Labour and Welfare (MHLW) granted special approval
Takeda CEO Says 2021 an 'Inflection Point' for Company
03:39pm, Thursday, 20'th May 2021
Takeda Pharmaceuticals Inc. ( TAK , Financial) has cleared the decks and sees smoother sailing ahead. That's according to the Japanese company's CEO, Christophe Weber.
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that primary analysis data from the Phase 2 OPTIC (Optimizing
Takeda Pharmaceutical Company Limited's (TAK) CEO Christophe Weber on Q4 2020 Results - Earnings Call Transcript
11:10am, Tuesday, 11'th May 2021
Takeda Pharmaceutical Company Limited's (TAK) CEO Christophe Weber on Q4 2020 Results - Earnings Call Transcript
Takeda says it may double imports of Moderna shots to help accelerate Japan vaccination
05:46am, Tuesday, 11'th May 2021
Takeda Pharmaceutical Co on Tuesday said it may double imports of Moderna Inc's COVID-19 vaccine to help Japan speed up COVID-19 inoculation efforts that have trailed most wealthy countries.
